A carregar...
Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 study
AIMS: The objective of this study was to evaluate the efficacy, safety, and tolerability of LY3015014 (LY), a neutralizing antibody of proprotein convertase subtilisin/kexin type 9 (PCSK9), administered every 4 or 8 weeks in patients with primary hypercholesterolaemia, when added to a background of...
Na minha lista:
| Publicado no: | Eur Heart J |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4852062/ https://ncbi.nlm.nih.gov/pubmed/26757788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv707 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|